Protein Kinase CK2: At the Crossroads of Pathways Controlling Cell Proliferation and Survival

Protein Kinase CK2

Volumn , Issue , 2013, Pages 169-189

  Gabriel, Michelle ^a   Litchfield, David W ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

Apoptosis; Cancer; Cell death; Cell proliferation; Cell survival

Indexed keywords

EID: 84886838390     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118482490.ch5     Document Type: Chapter

References (102)

1. Ahn NG, Resing KA. 2001. Toward the phospho-proteome. Nat Biotechnol 19:317.318.
2. Allende-Vega N, Dias S, Milne D, Meek D. 2005. Phosphorylation of the acidic domain of Mdm2 by protein kinase CK2. Mol Cell Biochem 274:85.90.
3. Bosc DG, Luscher B, Litchfield DW. 1999. Expression and regulation of protein kinase CK2 during the cell cycle. Mol Cell Biochem 191:213.222.
4. Bosc DG, Slominski E, Sichler C, Litchfield DW. 1995. Phosphorylation of casein kinase II by p34cdc2. Identification of phosphorylation sites using phosphorylation site mutants in vitro. J Biol Chem 270:25872.25878.
5. Buchou T, Vernet M, Blond O, Jensen HH, Pointu H, Olsen BB, Cochet C, Issinger OG, Boldyreff B. 2003. Disruption of the regulatory subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality. Mol Cell Biol 23: 908.915.
6. Burnett G, Kennedy EP. 1954. The enzymatic phosphorylation of proteins. J Biol Chem 2:969.980.
7. Capdeville R, Buchdunger E, Zimmermann J, Matter A. 2002. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov 1:493.502.
8. Channavajhala P, Seldin DC. 2002. Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis. Oncogene 21:5280.5288.
9. Cohen GM. 1997. Caspases: the executioners of apoptosis. Biochem J 326:1.16.
10. Cohen P. 2002. Protein kinases- the major drug targets of the twenty-first century? Nat Rev Drug Discov 1:309-315.
11. Chowdhury I, Tharakan B, Bhat GK. 2008. Caspases.an update. Comp Biochem Physiol B Biochem Mol Biol 151:10.27.
12. Daum JR, Gorbsky GJ. 1998. Casein kinase II catalyzes a mitotic phosphorylation on threo- nine 1342 of human DNA topoisomerase IIalpha, which is recognized by the 3F3/2 phosphoepitope antibody. J Biol Chem 273:30622.30629.
13. Daya-Makin M, Sanghera JS, Mogentale T, Lipp M, Parchomchuk J, Hogg J, Pelech S. 1994. Activation of a tumor-associated protein kinase (p40TAK) and casein kinase II in human squamous cell carcinomas and adenocarcinomas of the lung. Cancer Res 54: 2262.2268.
14. DePaoli-Roach AA. 1984. Synergistic phosphorylation and activation of ATP-Mg-dependent phosphoprotein phosphatase by FA/GSK-3 and casein kinase II (PC0.7). J Biol Chem 259: 12144.12152.
15. DePaoli-Roach AA, Ahmad Z, Roach PJ. 1981. Characterization of a rabbit skeletal muscle protein kinase (PC0.7) able to phosphorylate glycogen synthase and phosvitin. J Biol Chem 256:8955.8962.
16. Desagher S, Osen-Sand A, Montessuit S, Magnenat E, Vilbois F, Hochmann A, Journot L, Antonsson B, Martinou JC. 2001. Phosphorylation of bid by casein kinases I and II regu- lates its cleavage by caspase 8. Mol Cell 8:601.611.
17. Di Maira G, Brustolon F, Bertacchini J, Tosoni K, Marmiroli S, Pinna LA, Ruzzene M. 2007. Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance pheno- type of a CEM cell line characterized by high CK2 level. Oncogene 26:6915.6926.
18. Duncan JS, Turowec JP, Duncan KE, Vilk G, Wu C, Luscher B, Li SS, Gloor GB, Litchfield DW. 2011. A peptide-based target screen implicates the protein kinase CK2 in the global regulation of caspase signaling. Sci Signal 4(172):ra30.
19. Duncan JS, Turowec JP, Vilk G, Li SS, Gloor GB, Litchfield DW. 2010. Regulation of cell proliferation and survival: convergence of protein kinases and caspases. Biochim Biophys Acta 1804:505.510.
20. Escalier D, Silvius D, Xu X. 2003. Spermatogenesis of mice lacking CK2βiquest;βOElig;: Failure of germ cell survival and characteristic modifications of the spermatid nucleus. Mol Reprod Dev 66:190.201.
21. Escargueil AE, Plisov SY, Filhol O, Cochet C, Larsen AK. 2000. Mitotic phosphorylation of DNA topoisomerase II alpha by protein kinase CK2 creates the MPM-2 phosphoepitope on Ser-1469. J Biol Chem 275:34710.34718.
22. Faust M, Kartarius S, Schwindling SL, Montenarh M. 2002. Cyclin H is a new binding partner for protein kinase CK2. Biochem Biophys Res Commun 296:13.19.
23. Faust M, Schuster N, Montenarh M. 1999. Specific binding of protein kinase CK2 catalytic subunits to tubulin. FEBS Lett 462:51-56.
24. Faust RA, Gapany M, Tristani P, Davis A, Adams GL, Ahmed K. 1996. Elevated protein kinase CK2 activity in chromatin of head and neck tumours: association with malignant transformation. Cancer Lett 101:31.35.
25. Gietz RD, Graham KC, Litchfield DW. 1995. Interactions between the subunits of casein kinase II. J Biol Chem 270:13017.13021.
26. Giusiano S, Secq V, Carcopino X, Carpentier S, Andrac L, Lavaut MN, Allasia C, Bonnier P, Iovanna JL, Garcia S, Boubli L, Birnbaum D, Charpin C. 2010. Immunohistochemical profiling of node negative breast carcinomas allows prediction of metastatic risk. Int J Oncol 36:889.898.
27. Glover CV. 1998. On the physiological role of casein kinase II in Saccharomyces cerevisiae. Prog Nucleic Acid Res Mol Biol 59:95.133.
28. Gotz C, Kartarius S, Scholtes P, Nastainczyk W, Montenarh M. 1999. Identification of a CK2 phosphorylation site in mdm2. Eur J Biochem 266:493.501.
29. Gotz C, Kartarius S, Schwar G, Montenarh M. 2005. Phosphorylation of mdm2 at serine 269 impairs its interaction with the retinoblastoma protein. Int J Oncol 26:801.808.
30. Gotz C, Wagner P, Issinger OG, Montenarh M. 1996. p21WAF1/CIP1 interacts with protein kinase CK2. Oncogene 13:391.398.
31. Graham KC, Litchfield DW. 2000. The regulatory beta subunit of protein kinase CK2 medi- ates formation of tetrameric CK2 complexes. J Biol Chem 275:5003.5010.
32. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57.70.
33. Hjerrild M, Milne D, Dumaz N, Hay T, Issinger OG, Meek D. 2001. Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells. Biochem J 355:347.356.
34. Hunter T. 2000. Signaling.2000 and beyond. Cell 100:113.127.
35. Izeradjene K, Douglas L, Delaney A, Houghton JA. 2005. Casein kinase II (CK2) enhances death-inducing signaling complex (DISC) activity in TRAIL-induced apoptosis in human colon carcinoma cell lines. Oncogene 24:2050.2058.
36. Kapoor M, Lozano G. 1998. Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation. PNAS 95:2834.2837.
37. Keller DM, Lu H. 2002. p53 serine 392 phosphorylation increases after UV through induction of the assembly of the CK2.hSPT16.SSRP1 complex. J Biol Chem 277: 50206.50213.
38. Keller DM, Zeng X, Wang Y, Zhang QH, Kapoor M, Shu H, Goodman R, Lozano G, Zhao Y, Lu H. 2001. A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSPT16, and SSRP1. Mol Cell 7:283.292.
39. Kelliher MA, Seldin DC, Leder P. 1996. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase II alpha. EMBO J 15:5160.5166.
40. Kikkawa U, Mann SK, Firtel RA, Hunter T. 1992. Molecular cloning of casein kinase IIalpha subunit from Dictyostelium discoideum and expression in the life cycle. Mol Cell Biol 12:5711.5723.
41. Kim JS, Eom JI, Cheong JW, Choi AJ, Lee JK, Yang WI, Min YH. 2007. Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia. Clin Cancer Res 13:1019.1028.
42. Koseoglu MM, Graves LM, Marzluff WF. 2008. Phosphorylation of threonine 61 by cyclin a/Cdk1 triggers degradation of stem-loop binding protein at the end of S phase. Mol Cell Biol 28:4469.4479.
43. Krek W, Maridor G, Nigg EA. 1992. Casein kinase II is a predominantly nuclear enzyme. J Cell Biol 116:43.55.
44. Krippner-Heidenreich A, Talanian RV, Sekul R, Kraft R, Thole H, Ottleben H, Luscher B. 2001. Targeting of the transcription factor Max during apoptosis: phosphorylation- regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1. Biochem J 358:705.715.
45. Kurokawa M, Kornbluth S. 2009. Caspases and kinases in a death grip. Cell 138:838.854.
46. Landesman-Bollag E, Channavajhala PL, Cardiff RD, Seldin DC. 1998. p53 deficiency and misexpression of protein kinase CK2βiquest; collaborate in the development of thymic lympho- mas in mice. Oncogene 16:2965.2974.
47. Landesman-Bollag E, Romieu-Mourez R, Song DH, Sonenshein GE, Cardiff RD, Seldin DC. 2001. Protein kinase CK2 in mammary gland tumorigenesis. Oncogene 20:3247.3257.
48. Laramas M, Pasquier D, Filhol O, Ringeisen F, Descotes JL, Cochet C. 2007. Nuclear local- ization of protein kinase CK2 catalytic subunit is associated with poor prognostic factors in human prostate cancer. Eur J Cancer 43:928.934.
49. Li PF, Li J, Muller EC, Otto A, Dietz R, von Harsdorf R. 2002. Phosphorylation of protein kinase CK2: A signaling switch for the caspase-inhibiting protein ARC. Mol Cell 10:247.258.
50. Li Y, Keller DM, Scott JD, Lu H. 2005. CK2 phosphorylates SSRP1 and inhibits its DNA- binding activity. J Biol Chem 280:11869.11875.
51. Lin KY, Fang CL, Chen Y, Li CF, Chen SH, Kuo CY, Tai C, Uen YH. 2010. Overexpression of nuclear protein kinase CK2 Beta subunit and prognosis in human gastric carcinoma. Ann Surg Oncol 17:1695.1702.
52. Lin KY, Tai C, Hsu JC, Li CF, Fang CL, Lai HC, Hseu YC, Lin YF, Uen YH. 2011. Overex- pression of nuclear protein kinase CK2βiquest; catalytic subunit as a poor prognostic in human colorectal cancer. PLoS One 6:e17193.
53. Lindqvist A, Rodriguez-Bravo V, Medema RH. 2009. The decision to enter mitosis: feedback and redundancy in the mitotic entry network. J Cell Biol 185:193.202.
54. Litchfield DW. 2003. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem J 369:1.15.
55. Litchfield DW, Arendt A, Lonzeman FJ, Krebs EG, Hargrave PA, Palczewski K. 1990. Syn- thetic phophopeptides are substrates for casein kinase II. FEBS Lett 261:117.120.
56. Litchfield DW, Lozeman FJ, Cicirelli MF, Harrylock M, Ericsson LH, Piening CJ, Krebs EG. 1991. Phosphorylation of the beta subunit of casein kinase II in human A431 cells. Iden- tification of the autophorphorylation site and a site phosphorylated by p34cdc2. J Biol Chem 266:20380.20389.
57. Litchfield DW, Luscher B, Lozeman FJ, Eisenman RN, Krebs EG. 1992. Phosphorylation of casein kinase II by p34cdc2 in vitro and at mitosis. J Biol Chem 267:13943.13951.
58. Lolli G, Johnson LN. 2005. CAK-Cyclin-dependent Activating Kinase: a key kinase in cell cycle control and a target for drugs? Cell Cycle 4:572.577.
59. Lou DY, Dominguez I, Toselli P, Landesman-Bollag E, O'Brien C, Seldin DC. 2008. The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic develop- ment. Mol Cell Biol 28:131.139.
60. Lozeman FJ, Litchfield DW, Piening C, Takio, K, Walsh KA, Krebs EG. 1990. Isolation and characterization of human cDNA clones encoding the alpha and alphaβOElig; subunits of casein kinase II. Biochemistry 29:8436.8447.
61. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. 2002. The Protein Kinase Complement of the Human Genome. Science 298:1912.1934.
62. McDonnell MA, Abedin MJ, Melendez M, Platikanova TN, Ecklund JR, Ahmed K, Kelekar A. 2009. Phosphorylation of murine caspase-9 by the protein kinase casein kinase 2 regu- lates its cleavage by caspase-8. J Biol Chem 283:20149.20158.
63. Messenger MM, Saulnier RB, Gilchrist AD, Diamond P, Gorbsky GJ, Litchfield DW. 2002. Interactions between protein kinase CK2 and Pin1. Evidence for phosphorylation- dependent interactions. J Biol Chem 277:23054.23064.
64. Nasmyth K. 1996. Viewpoint: putting the cell cycle in order. Science 274:1643.1645.
65. Niefind K, Guerra B, Ermakowa I, Issinger OG. 2001. Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme. EMBO J 20:5320.5331.
66. Niefind K, Putter M, Guerra B, Issinger OG, Schomburg D. 1999. GTP plus water mimic ATP in the active site of protein kinase CK2. Nat Struct Biol 6:1100.1103.
67. Pepperkok R, Lorenz P, Ansorge W, Pyerin W. 1994. Casein kinase II is required for transition of G0/G1, early G1, and G1/S phases of the cell cycle. J Biol Chem 269:6986.6991.
68. Piazza F, Manni S, Ruzzene M, Pinna LA, Gurrieri C, Semenzato G. 2012. Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by onco- genic signaling pathways. Leukemia doi:10.1038/leu.2011.385.
69. Pierre F, Chua PC, O'Brien SE, Siddiqui-Jain A, Bourbon P, Haddach M, Michaux J, Nagasawa J, Schwaebe MK, Stefan E, Vialettes A, Whitten JP, Chen TK, Darjania L, Bliesath J, Drygin D, Ho C, Omori M, Proffitt C, Streiner N, Rice WG, Ryckman DM, Anderes K. 2011. Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer. Mol Cell Biochem 356:37.43.
70. Pinna LA. 1990. Casein kinase 2: an geminence griseh in cellular regulation?. Biochim Biophys Acta 1054:267-284.
71. Pinna LA, Meggio F. 1997. Protein kinase CK2 and its implication in cell division and proliferation. Prog Cell Cycle Res 3:77.97.
72. Retinaswamy A, Birnbaum MJ, Glover CV. 1998. Temperature-sensitive mutations of the CKA1 gene reveal a role for casein kinase II in maintenance of cell polarity in Saccha- romyces cerevisiae. J Biochem 10:5869.5877.
73. Riman S, Rizkallah R, Kassardjian A, Alexander KE, Luscher B, Hurt MM. 2012. Phosphory- lation of the transcription factor YY1 by CK2βiquest; prevents cleavage by caspase 7 during apoptosis. Mol Cell Biol 32:797.807.
74. Romero-Oliva F, Allende JE. 2001. Protein p21(WAF1/CIP1) is phosphorylated by protein kinase CK2 in vitro and interacts with the amino terminal end of the CK2 beta subunit. J Cell Biochem 81:445.452.
75. Ruzzene M, Penzo D, Pinna LA. 2002. Protein kinase CK2 inhibitor TBB induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells. Biochem J 364:41.47.
76. Salvi M, Sarno S, Cesaro L, Nakamura H, Pinna LA. 2009. Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysis. Biochim Biophys Acta 1973:847.859.
77. Sayed M, Pelech S, Wong C, Marotta A, Salh B. 2001. Protein kinase CK2 is involved in G2 arrest and apoptosis following spindle damage in epithelial cells. Oncogene 20: 6994.7005.
78. Schneider E, Kartarius S, Schuster N, Montenarh M. 2002. The cyclin H/cdk7/Mat1 kinase activity is regulated by CK2 phosphorylation of cyclin H. Oncogene 21:5031.5037.
79. Schwindling SL, Noll A, Montenarh M, Gotz C. 2004. Mutation of a CK2 phosphorylation site in cdc25C impairs importin alpha/beta binding and results in cytoplasmic retention. Oncogene 23:4155.4165.
80. Shen Y, White E. 2001. p53-dependent apoptosis pathways. Adv Cancer Res 82:55.84.
81. Sherr CJ, McCormick F. 2002. The RB and p53 pathways in cancer. Cancer Cell 2:103.112.
82. Shin S, Lee Y, Kim W, Ko H, Choi H, Kim K. 2005. Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8. EMBO J 24:3532.3542.
83. Stalter G, Siemer S, Becht E, Ziegler M, Remberger K, Issinger O. 1994. Asymmetric expres- sion of protein kinase CK2 subunits in human kidney tumors. Biochem Biophys Res Commun 202:190.201.
84. St-Denis NA, Bailey ML, Parker EL, Vilk G, Litchfield DW. 2011. Localization of phos- phorylated CK2alpha to the mitotic spindle requires the peptidyl-prolyl isomerase Pin1. J Cell Sci 124:2341.2348.
85. St-Denis NA, Derksen DR, Litchfield DW. 2009. Evidence for regulation of mitotic progres- sion through temporal phosphorylation and dephosphorylation of CK2alpha. Mol Cell Biol 29:2068.2081.
86. St-Denis NA, Litchfield DW. 2009. Protein kinase CK2 in health and disease: From birth to death: the role of protein kinase CK2 in the regulation of cell proliferation and survival. Cell Mol Life Sci 66:1817.1829.
87. Tapia JC, Bolanos-Garcia VM, Sayed M, Allende CC, Allende JE. 2004. Cell cycle regulatory protein p27KIP1 is a substrate and interacts with protein kinase CK2. J Cell Biochem 91:865.879.
88. Tapia JC, Torres VA, Rodriguez DA, Leyton L, Quest AF. 2006. Casein kinase 2 increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription. PNAS 103:15079.15084.
89. Theis-Febvre N, Filhol O, Froment C, Cazales M, Cochet C, Monsarrat B, Ducommun B, Baldin V. 2003. Protein kinase CK2 regulates CDC25B phosphatase activity. Oncogene 22:220.232.
90. Torres J, Rodriguez J, Myers MP, Valiente M, Graves JD, Tonks NK, Pulido R. 2003. Phosphorylation-regulated cleavage of the tumor suppressor PTEN by caspase-3: implica- tions for the control of protein stability and PTEN-protein interactions. J Biol Chem 278:30652.30660.
91. Turowec JP, Duncan JS, Gloor GB, Litchfield DW. 2011. Regulation of caspase pathways by protein kinase CK2: identification of proteins with overlapping CK2 and caspase consen- sus motifs. Mol Cell Biochem 356:159.167.
92. Vermeulen K, Van Bockstaele DR, Berneman ZN. 2005. Apoptosis: mechanisms and rele- vance in cancer. Ann Hematol 84:627.639.
93. Walter J, Schindzielorz A, Grunberg J, Haass C. 1999. Phosphorylation of presenilin-2 regulates its cleavage by caspases and retards progression of apoptosis. PNAS 96: 1391.1396.
94. Wang G, Ahmad KA, Ahmed K. 2006. Role of protein kinase CK2 in the regulation of tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis in prostate cancer cells. Cancer Res 66:2242.2249.
95. Wang G, Unger G, Ahmad KA, Slaton JW, Ahmed K. 2005. Downregulation of CK2 induces apoptosis in cancer cells.a potential approach to cancer therapy. Mol Cell Biochem 274:77.84.
96. Watanabe N, Arai H, Iwasaki J, Shiina M, Ogata K, Hunter T, Osada H. 2005. Cyclin- dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple path- ways. PNAS 102:11663.11668.
97. Woodgett JR, Cohen P. 1984. Multisite phosphorylation of glycogen synthase. Molecular basis for the substrate specificity of glycogen synthase kinase-3 and casein kinase-II. Biochim Biophys Acta 788:339.347.
98. Xu X, Toselli PA, Russell LD, Seldin DC. 1999. Globozoospermia in mice lacking the casein kinase II alphaβOElig; catalytic subunit. Nat Genet 23:118.121.
99. Yamane K, Kinsella TJ. 2005. CK2 inhibits apoptosis and changes its cellular localization following ionizing radiation. Cancer Res 64:4362.4367.
100. Yata K, Lloyd J, Maslen S, Bleuyard JY, Skehel M, Smerdon SJ, Esashi F. 2012. Plk1 and CK2 act in concert to regulate Rad51 during DNA double strand break repair. Mol Cell 45:371.383.
101. Yin X, Gu S, Jiang JX. 2001. The development-associated cleavage of lens connexin 45.6 by caspase-3-like protease is regulated by Casein kinase II-mediated phosphorylation. J Biol Chem 278:30652.30660.
102. Yu IJ, Spector DL, Bae YS, Marshak DR. 1991. Immunocytochemical localization of casein kinase II during interphase and mitosis. J Cell Biol 114:1217.1232.